We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
ABOUT US / INKE
Development and manufacturing of APIs

DEVELOPS AND MANUFACTURES THE HIGHEST QUALITY ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

with complex synthesis processes, mainly for use in respiratory and CNS therapies
High-added-value active pharmaceutical ingredients
for use in respiratory therapies such as:
ARFORMOTEROL · FORMOTEROL · GLYCOPYRROLATE · INDACATEROL · SALMETEROL · TIOTROPIUM
BRANDINKE_METAS_ACTIVITIES_ALT

OUR ACTIVITIES

  • Neuraxpharm INKE, a wholly-owned subsidiary of Neuraxpharm, has been manufacturing the highest quality API since 1980
  • Development and manufacturing of APIs Development and manufacturing of API with complex synthesis process
  •  micronisation More than 20 years' experience in micronisation
  • Inke delivers APIs all over the world Continuous international expansion since 1998
  • selling APIs to more than 30 countries Strong international presence with the sale of APIs to more than 30 countries
selling APIs to more than 30 countries
FOCUS_METAS_INTERNATIONAL_ALT
Headquartered in Barcelona (Spain)
In continuous international
expansion since 1998,
Inke delivers APIs all over the world, including Europe, the US, Japan, Korea and China
Inke has been successfully inspected by every major global authority for a wide array of products (last US-FDA inspection in May 2016)

For the last two decades, the company has made great strides to become a prestigious provider of respiratory APIs for inhalation
BRANDINKE_METAS_HOLDS_ALT

INKE
HAS A STRONG
WORLDWIDE

reputation and brand image